<SEC-DOCUMENT>0001104659-22-091415.txt : 20220815 <SEC-HEADER>0001104659-22-091415.hdr.sgml : 20220815 <ACCEPTANCE-DATETIME>20220815181059 ACCESSION NUMBER: 0001104659-22-091415 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220815 DATE AS OF CHANGE: 20220815 EFFECTIVENESS DATE: 20220815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACUTA CAPITAL PARTNERS, LLC CENTRAL INDEX KEY: 0001582844 IRS NUMBER: 452817402 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16527 FILM NUMBER: 221167463 BUSINESS ADDRESS: STREET 1: 1301 SHOREWAY ROAD STREET 2: SUITE 350 CITY: BELMONT STATE: CA ZIP: 94002 BUSINESS PHONE: 650-529-8000 MAIL ADDRESS: STREET 1: 1301 SHOREWAY ROAD STREET 2: SUITE 350 CITY: BELMONT STATE: CA ZIP: 94002 FORMER COMPANY: FORMER CONFORMED NAME: Longwood Capital Partners LLC DATE OF NAME CHANGE: 20130730 </SEC-HEADER> <DOCUMENT> <TYPE>13F-HR <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> <XML> <?xml version="1.0" encoding="UTF-8"?> <edgarSubmission xsi:schemaLocation="http://www.sec.gov/edgar/thirteenffiler eis_13F_Filer.xsd" xmlns="http://www.sec.gov/edgar/thirteenffiler" xmlns:ns1="http://www.sec.gov/edgar/common" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> <headerData> <submissionType>13F-HR</submissionType> <filerInfo> <liveTestFlag>LIVE</liveTestFlag> <flags> <confirmingCopyFlag>false</confirmingCopyFlag> <returnCopyFlag>false</returnCopyFlag> <overrideInternetFlag>false</overrideInternetFlag> </flags> <filer> <credentials> <cik>0001582844</cik> <ccc>XXXXXXXX</ccc> </credentials> </filer> <periodOfReport>06-30-2022</periodOfReport> </filerInfo> </headerData> <formData> <coverPage> <reportCalendarOrQuarter>06-30-2022</reportCalendarOrQuarter> <isAmendment>false</isAmendment> <filingManager> <name>ACUTA CAPITAL PARTNERS, LLC</name> <address> <ns1:street1>1301 Shoreway Road</ns1:street1> <ns1:street2>Suite 350</ns1:street2> <ns1:city>Belmont</ns1:city> <ns1:stateOrCountry>CA</ns1:stateOrCountry> <ns1:zipCode>94002</ns1:zipCode> </address> </filingManager> <reportType>13F HOLDINGS REPORT</reportType> <form13FFileNumber>028-16527</form13FFileNumber> <provideInfoForInstruction5>N</provideInfoForInstruction5> </coverPage> <signatureBlock> <name>Scott Smith</name> <title>Chief Operating Officer</title> <phone>650-486-0581</phone> <signature>/s/ Scott Smith</signature> <city>Belmont</city> <stateOrCountry>CA</stateOrCountry> <signatureDate>08-15-2022</signatureDate> </signatureBlock> <summaryPage> <otherIncludedManagersCount>0</otherIncludedManagersCount> <tableEntryTotal>43</tableEntryTotal> <tableValueTotal>179499</tableValueTotal> </summaryPage> </formData> </edgarSubmission> </XML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>INFORMATION TABLE <SEQUENCE>2 <FILENAME>infotable.xml <TEXT> <XML> <?xml version="1.0" ?> <informationTable xsi:schemaLocation="http://www.sec.gov/edgar/document/thirteenf/informationtable eis_13FDocument.xsd" xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:n1="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> <infoTable> <nameOfIssuer>AADI BIOSCIENCES INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>00032Q104</cusip> <value>18842</value> <shrsOrPrnAmt> <sshPrnamt>1529402</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>1529402</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>AC IMMUNE SA</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>99P1VHX22</cusip> <value>354</value> <shrsOrPrnAmt> <sshPrnamt>100000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <putCall>Call</putCall> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>100000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>ACADIA PHARMACEUTICALS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>004225108</cusip> <value>1007</value> <shrsOrPrnAmt> <sshPrnamt>71500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>71500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>ACLARIS THERAPEU</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>00461U105</cusip> <value>2692</value> <shrsOrPrnAmt> <sshPrnamt>192835</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>192835</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>APELLIS PHARMACEUTICALS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>03753U106</cusip> <value>25052</value> <shrsOrPrnAmt> <sshPrnamt>554000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>554000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>ARCUS BIOSCIENCES INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>03969F109</cusip> <value>4244</value> <shrsOrPrnAmt> <sshPrnamt>167500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>167500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>ARROWHEAD PHARMACEUTICALS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>04280A100</cusip> <value>2180</value> <shrsOrPrnAmt> <sshPrnamt>61926</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>61926</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>ATHIRA PHARMA INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>99P19TV23</cusip> <value>340</value> <shrsOrPrnAmt> <sshPrnamt>100000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <putCall>Call</putCall> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>100000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>BCLS ACQUISITION CORP- CL A</nameOfIssuer> <titleOfClass>COM CL A</titleOfClass> <cusip>G0904B105</cusip> <value>8347</value> <shrsOrPrnAmt> <sshPrnamt>843122</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>843122</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>BELLUS HEALTH INC</nameOfIssuer> <titleOfClass>COM NEW</titleOfClass> <cusip>07987C204</cusip> <value>7540</value> <shrsOrPrnAmt> <sshPrnamt>816000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>816000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>CELLDEX THERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM NEW</titleOfClass> <cusip>15117B202</cusip> <value>7204</value> <shrsOrPrnAmt> <sshPrnamt>267195</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>267195</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>ENANTA PHARMACEUTICALS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>29251M106</cusip> <value>1300</value> <shrsOrPrnAmt> <sshPrnamt>27500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>27500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>EYEPOINT PHARMACEUTICALS INC</nameOfIssuer> <titleOfClass>COM NEW</titleOfClass> <cusip>30233G209</cusip> <value>2388</value> <shrsOrPrnAmt> <sshPrnamt>303396</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>303396</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>FULCRUM THERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>359616109</cusip> <value>980</value> <shrsOrPrnAmt> <sshPrnamt>200000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>200000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>GH RESEARCH PLC</nameOfIssuer> <titleOfClass>ORDINARY SHARES</titleOfClass> <cusip>G3855L106</cusip> <value>2428</value> <shrsOrPrnAmt> <sshPrnamt>243250</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>243250</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>GOSSAMER BIO INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>38341P102</cusip> <value>268</value> <shrsOrPrnAmt> <sshPrnamt>32000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>32000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>HEALTH SCIENCES ACQUISITIONS</nameOfIssuer> <titleOfClass>ORD SHS</titleOfClass> <cusip>G4411D109</cusip> <value>3909</value> <shrsOrPrnAmt> <sshPrnamt>392500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>392500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>HORIZON THERAPEUTICS PLC</nameOfIssuer> <titleOfClass>SHS</titleOfClass> <cusip>G46188101</cusip> <value>2862</value> <shrsOrPrnAmt> <sshPrnamt>35888</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>35888</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>IOVANCE BIOTHERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>462260100</cusip> <value>1704</value> <shrsOrPrnAmt> <sshPrnamt>154356</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>154356</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>ITEOS THERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>46565G104</cusip> <value>1277</value> <shrsOrPrnAmt> <sshPrnamt>62000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>62000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>IVERIC BIO INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>46583P102</cusip> <value>5422</value> <shrsOrPrnAmt> <sshPrnamt>563607</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>563607</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>JIYA ACQUISITION CORP -CL A</nameOfIssuer> <titleOfClass>COM CL A</titleOfClass> <cusip>47760M102</cusip> <value>5552</value> <shrsOrPrnAmt> <sshPrnamt>562500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>562500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>KURA ONCOLOGY INC. COMMON STOCK</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>50127T109</cusip> <value>9834</value> <shrsOrPrnAmt> <sshPrnamt>536500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>536500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>MERUS BV</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>N5749R100</cusip> <value>3487</value> <shrsOrPrnAmt> <sshPrnamt>154000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>154000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>MILESTONE PHARMACEUTICALS IN</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>59935V107</cusip> <value>2812</value> <shrsOrPrnAmt> <sshPrnamt>457200</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>457200</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>MIRATI THERAPEUTICS</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>60468T105</cusip> <value>6344</value> <shrsOrPrnAmt> <sshPrnamt>94500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>94500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>NUVATION BIO INC</nameOfIssuer> <titleOfClass>*W EXP 07/07/202</titleOfClass> <cusip>67080N119</cusip> <value>25</value> <shrsOrPrnAmt> <sshPrnamt>90832</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>90832</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>OCULAR THERAPEUTIX INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>67576A100</cusip> <value>53</value> <shrsOrPrnAmt> <sshPrnamt>13171</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>13171</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>PMV PHARMACEUTICALS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>69353Y103</cusip> <value>2173</value> <shrsOrPrnAmt> <sshPrnamt>152500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>152500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>PRECISION BIOSCIENCES INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>74019P108</cusip> <value>3281</value> <shrsOrPrnAmt> <sshPrnamt>2050359</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>2050359</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>PYXIS ONCOLOGY INC</nameOfIssuer> <titleOfClass>COMMON STOCK</titleOfClass> <cusip>747324101</cusip> <value>1535</value> <shrsOrPrnAmt> <sshPrnamt>645149</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>645149</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>RELMADA THERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>75955J402</cusip> <value>6694</value> <shrsOrPrnAmt> <sshPrnamt>352500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>352500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>REZOLUTE INC</nameOfIssuer> <titleOfClass>COM NEW</titleOfClass> <cusip>76200L309</cusip> <value>2084</value> <shrsOrPrnAmt> <sshPrnamt>645136</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>645136</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>ROCHE GS</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>993960LE1</cusip> <value>5338</value> <shrsOrPrnAmt> <sshPrnamt>16000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>16000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>SPRINGWORKS THERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>85205L107</cusip> <value>123</value> <shrsOrPrnAmt> <sshPrnamt>5000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>5000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>SYNDAX PHARMACEUTICALS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>87164F105</cusip> <value>3944</value> <shrsOrPrnAmt> <sshPrnamt>205003</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>205003</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>TREVI THERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>89532M101</cusip> <value>98</value> <shrsOrPrnAmt> <sshPrnamt>35000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>35000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>UNITED THERAPEUTICS CORP DEL</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>91307C102</cusip> <value>3063</value> <shrsOrPrnAmt> <sshPrnamt>13000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>13000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>VENTYX BIOSCIENCES INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>92332V107</cusip> <value>1492</value> <shrsOrPrnAmt> <sshPrnamt>122000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>122000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>VERASTEM INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>92337C104</cusip> <value>232</value> <shrsOrPrnAmt> <sshPrnamt>200000</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>200000</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>VIRIDIAN THERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>92790C104</cusip> <value>2708</value> <shrsOrPrnAmt> <sshPrnamt>234026</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>234026</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>VISTAGEN THERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM NEW</titleOfClass> <cusip>92840H202</cusip> <value>9998</value> <shrsOrPrnAmt> <sshPrnamt>11361451</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>11361451</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> <infoTable> <nameOfIssuer>XENON PHARMACEUTICALS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>98420N105</cusip> <value>8289</value> <shrsOrPrnAmt> <sshPrnamt>272500</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>SOLE</investmentDiscretion> <votingAuthority> <Sole>272500</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> </informationTable> </XML> </TEXT> </DOCUMENT> </SEC-DOCUMENT>